Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Monday, September 26, 2011 - 11:31am
tags:
Roche, HDL therapy, Merck, dalcetrapib, Anacetrapib
Teva breaking ground on $300M Phila. distribution center
Bizjournals.com
Monday, September 26, 2011 - 11:13am
tags:
Teva Pharmaceuticals, distribution
Lilly receives positive European opinion on Alimta
Yahoo/AP
Monday, September 26, 2011 - 11:12am
tags:
Europe, lung cancer, Alimta, Eli Lilly
Alexion Pharma on a High
Yahoo/Zacks.com
Monday, September 26, 2011 - 11:12am
tags:
Alexion, Soliris, aHUS, atypical hemolytic uremic syndrome
Jefferies analyst upgrades Alkermes to 'buy' after completion of acquisition, move to Ireland
Yahoo/AP
Monday, September 26, 2011 - 11:03am
tags:
Alkermes, M&A, drug delivery, Elan
Teva buys rest of Japan venture from Kowa at $150M
Marketwatch
Monday, September 26, 2011 - 11:00am
tags:
Kowa, Japan, Teva Pharmaceuticals, M&A
Cancer Cost Swells, Risks Becoming ‘Unsustainable,’ Lancet Says
Bloomberg
Monday, September 26, 2011 - 10:58am
tags:
cancer
9 Big Pharmas With The Least Side Effects
Seeking Alpha
Monday, September 26, 2011 - 10:57am
tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Human Genome Spikes On Sales: Good Time To Consider Buying
Seeking Alpha
Monday, September 26, 2011 - 10:56am
tags:
Human Genome Sciences, GSK, Benlysta, lupus
Teva Tumbles to Lowest Since 2006 on EU Review of Cephalon
BusinessWeek
Sunday, September 25, 2011 - 1:12pm
tags:
Teva Pharmaceuticals, Cephalon
Ireland Beckons Biotech Business
Chemical and Engineering News
Sunday, September 25, 2011 - 1:09pm
tags:
Ireland
Paladin Considers Options Following Alternate Offer for Afexa
Stock Markets Review
Sunday, September 25, 2011 - 1:08pm
tags:
Paladin, Afexa, Valeant Pharmaceuticals, M&A
Debunking Corporate Venture Capital in Biotech
Forbes
Sunday, September 25, 2011 - 1:05pm
tags:
venture capital
Johnson & Johnson's Xarelto Not a Cure for Pipeline Concerns
Seeking Alpha
Sunday, September 25, 2011 - 1:05pm
tags:
JNJ, Xarelto
Siga's Setback Promises Gains For PharmAthene
Seeking Alpha
Sunday, September 25, 2011 - 12:59pm
tags:
PharmAthene, SIGA technologies
Anything Positive At Enzon?
Seeking Alpha
Sunday, September 25, 2011 - 12:58pm
tags:
Enzon
T-DM1 Significantly Improved Progression-Free Survival Compared to Standard of Care for Previously Untreated HER2-Positive Metastatic Breast Cancer
Yahoo/GlobeNewswire
Sunday, September 25, 2011 - 12:57pm
tags:
trastuzumab, T-DM1, breast cancer, Immunogen
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Seeking Alpha
Sunday, September 25, 2011 - 12:55pm
tags:
Amyris, NPS Pharmaceuticals, Targacept, Sequenom, Cadence Pharmaceuticals, Enzon, Dendreon, Incyte
Novartis cutting 2,500 jobs globally
Reuters
Saturday, September 24, 2011 - 1:29pm
tags:
Novartis
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Saturday, September 24, 2011 - 1:26pm
tags:
Bone metastases, prostate cancer, Alpharadin, Algeta, Bayer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.